CIK: 0001637359
Total reported value
$163.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | KMTS | Kestra Medical Technologies, Ltd. | Stock-Other | 17.59% | -0.22% | — | |
| 2 | BBNX | Beta Bionics INC | Stock-Other | 17.16% | -5.92% | -3.43% | |
| 3 | BBOT | Bridgebio Oncology Therapeut | Stock-Other | 17.13% | +3.68% | — | |
| 4 | BCAX | Bicara Therapeutics INC | Stock-Other | 15.66% | +16.21% | — | |
| 5 | NUVB | Nuvation Bio INC | Stock-Other | 14.69% | -4.02% | -20.03% | |
| 6 | UPB | Upstream Bio INC | Stock-Other | 11.47% | -12.57% | EXIT | |
| 7 | IMA | Imagenebio INC | Stock-Other | 1.67% | +0.30% | — | |
| 8 | ✓ | Engene Holdings INC | Stock-Other | 1.62% | +0.90% | — | |
| 9 | SANA | Sana Biotechnology INC | Stock-Other | 1.35% | +0.29% | — | |
| 10 | ALMS | Alumis INC | Stock-Other | 1.17% | +1.03% | — | |
| 11 | REPL | Replimune Group INC | Stock-Other | 0.47% | +0.33% | -87.41% | |
| 12 | ✓ | Engene Holdings INC | Stock-Other | 0.03% | — | -72.10% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | UPB | Upstream Bio INC | +4.1% | -33.39% | Trim |
| 2 | BBNX | Beta Bionics INC | +2.8% | -3.43% | Trim |
| 3 | NUVB | Nuvation Bio INC | +1.1% | -20.03% | Trim |
| 4 | SANA | Sana Biotechnology INC | +0.5% | — | Unchanged |
| 5 | ✓ | Engene Holdings INC | +0.2% | — | Unchanged |
| 6 | ✓ | Engene Holdings INC | -0.1% | -72.10% | Trim |
| 7 | ALMS | Alumis INC | -1.2% | — | Unchanged |
| 8 | BCAX | Bicara Therapeutics INC | -1.3% | — | Unchanged |
| 9 | KMTS | Kestra Medical Technologies, Ltd. | -8.8% | — | Trim |
| 10 | REPL | Replimune Group INC | -10.9% | -87.41% | Trim |
| 11 | BBOT | Bridgebio Oncology Therapeut | — | NEW | New buy |
| 12 | LXEO | Lexeo Therapeutics INC | — | EXIT | Sold out |
| 13 | IMA | Imagenebio INC | — | NEW | New buy |
| 14 | ✓ | Ikena Oncology INC | — | EXIT | Sold out |
| 15 | VTLUSD | Immunic INC | — | EXIT | Sold out |